1st Quarter - Report

BALCH & BINGHAM, LLP for VAXIN PHARMACEUTICALS INC

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Funding for Immunocontraceptive vaccines through Department of Interior, Agriculture or Transportation Appropriations bills; in ovo vaccination by recombinant adenovirus vectors through Department of Agriculture or Homeland Security Appropriations bills; non-invasive vectored vaccine research through Department of Defense Authorization or Defense Appropriations bills.

LobbyistCovered position, as disclosed
MICHAEL J DAVIS Field Representative - Sen. Jeff Sessions
WILLIAM F STIERS Leg. Dir. - Reps. Wm. Dickinson and Terry Everett

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.